Life

Health, science, climate, and society-focused reporting.

Briefing: Analysis of Medicare data shows who mental health providers treat over telehealth

Strategic angle: A new analysis reveals that mental health specialists utilizing telehealth did not significantly increase their rural patient base.

Editorial Staff Mar 12

Life

Briefing: STAT+: Pharmalittle: We’re reading about telehealth prescribers, a Lilly push against compounding, and more

Strategic angle: Medical groups affiliated with telehealth companies the FDA warned about marketing of compounded weight loss drugs may be under the microscope, too

Editorial Staff Mar 12

Life

Briefing: An NIH Whistleblower Warning

Strategic angle: The doctors behind the telehealth GLP-1 boom, a men's health office moment, and other health news

Editorial Staff Mar 12

Life

Briefing: Officials Amplify Fluoride Concerns as Federal Review and State Restrictions Advance

Strategic angle: The EPA's safety review of fluoride coincides with growing state-level bans on community water fluoridation.

Editorial Staff Mar 12

Life

Briefing: STAT+: Is Aldeyra Therapeutics waving red flags with consequences?

Strategic angle: How often do drugmakers complain about short sellers in SEC filings? And does it do any good?

Editorial Staff Mar 12

Life

Briefing: FDA Targets Telehealth Marketing of GLP-1 Drugs

Strategic angle: The FDA is scrutinizing telehealth marketing practices for GLP-1 drugs, raising questions about prescribing trends.

Editorial Staff Mar 12

Life

Briefing: Momentum builds for a federal office of men’s health focused on disease prevention

Strategic angle: For advocates who have been pushing to create a federal office of men's health, this could finally be the moment.

Editorial Staff Mar 12

Life

Briefing: Key Facts About Medicare Drug Price Negotiation

Strategic angle: The federal government negotiates prices for high-cost drugs under Medicare Part B and Part D.

Editorial Staff Mar 11

Life

Novo Nordisk is warned by the FDA for failing to report side effects

It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.

Editorial Staff Mar 11

Life

Briefing: This billionaire wants to make science better, especially for AI

Strategic angle: In this edition of AI Prognosis: Seemay Chou and Becky Pferdehirt's bold vision for how Radial will change science for AI

Editorial Staff Mar 11

Life

Briefing: How Does Health Spending in the U.S. Compare to Other Countries?

Strategic angle: This analysis examines how U.S. health spending compares to health spending in other high-income nations.

Editorial Staff Mar 11

Life

Briefing: Red states hit hardest by reduced NIH funding

Strategic angle: Epstein's "great friend" returns to biotech, sex differences in suicide, and other health news from Morning Rounds

Editorial Staff Mar 11

Life

Briefing: New nonprofit launches with at least $500 million to modernize scientific process for AI era

Strategic angle: Radial aims to transform the scientific landscape to better integrate artificial intelligence.

Editorial Staff Mar 11

Life

Briefing: AI Agents in Health Care: Rapid Spread and Validation Concerns

Strategic angle: Experts at HIMSS 2026 raise alarms over the lack of validation for AI agents in health care.

Editorial Staff Mar 11

Life

Briefing: Opinion: I’m a medical student. RFK Jr. is right about medical school and preventive care

Strategic angle: In medical school, a student writes, she has learned to react first, focus on prevention later.

Editorial Staff Mar 11

Life

Briefing: STAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback

Strategic angle: Boris Nikolic’s career looked to be in tatters after his friendship with Jeffrey Epstein came to light in 2019. But he has quietly made a comeback, with some help from…

Editorial Staff Mar 11

Life

Briefing: How Does Cost Affect Access to Health Care?

Strategic angle: This analysis explores trends in how the cost of healthcare affects access to care in the U.S.

Editorial Staff Mar 10

Life

Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections

Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.

Editorial Staff Mar 10

Life

Briefing: What’s next for RFK Jr.’s MAHA allies on vaccine policy?

Strategic angle: A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned.

Editorial Staff Mar 10

Life

BioNTech Founders to Depart, Form New mRNA-Focused Company

Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, mRNA-focused firm.

Editorial Staff Mar 10